Team Member Spotlight: Seth Hammack, application engineer -

Team Member Spotlight: Seth Hammack, application engineer

  • Seth Hammack, application engineer

Seth Hammack, application engineer, enjoys working with customers to understand and solve complicated fluid control problems. “I’ve always liked being a problem solver,” he said. “My father has a masonry business and I worked with him growing up. My specialty was helping to fix equipment and find solutions to other issues. One of the reasons I wanted to go into engineering was because it’s a way to solve problems.”

Since joining Equilibar in August, Seth has been intrigued to learn all the different ways customers use Equilibar devices. “For such a simple concept, the Equilibar technology has an incredibly wide range of uses. So far, I think one of the most interesting applications to me is electrolysis because it’s on the forefront of engineering.”

Seth graduated from North Carolina State University in May with a degree in mechanical engineering. One of his academic interests was automotive combustion, including undergraduate research in fluid dynamics. This experience carries over into several of Equilibar’s applications, including some hydrogen energy processes.

Seth has deep roots in the North Carolina mountains, growing up in Alleghany County near the Virginia state line. He decided to live in the Asheville area because it offers outdoor activities as well as more urban attractions. He looks forward to exploring the many breweries in the area as well as the nearby forests and green spaces with his fiancée, who is an environmental educator.

In his spare time, Seth practices martial arts and enjoys traveling and exploring different types of food. His goal at work is to serve as an interface between design and applications, especially on custom valves, and to discover even more ways to use Equilibar devices.

If you have a fluid control problem, we invite you to contact Seth and our other application engineers. They look forward to hearing from you.

Categories
Equilibar News
PUK magazine cover with stainless steel device

Journal article focuses on oligonucleotide production using pressure control with built in dampener

Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic.  Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More

Read More